Floseal Treatment for Posterior Epistaxis Study
Effectiveness of Floseal for the treatment of posterior epistaxis.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Floseal Posterior Epistaxis Pilot Study (PEPIS)|
- Effectiveness of Floseal for the treatment of posterior epistaxis. [ Time Frame: Immediate effect with 1 hour observation and follow-up at 5 and 30 days following treatment. ] [ Designated as safety issue: No ]
- Cost savings of Floseal treatment in comparison to posterior packing, surgical, and embolisation treatments for posterior epistaxis. [ Time Frame: 30 days ] [ Designated as safety issue: No ]
|Study Start Date:||April 2010|
|Study Completion Date:||November 2011|
|Primary Completion Date:||November 2011 (Final data collection date for primary outcome measure)|
Will receive Floseal treatment for posterior epistaxis.
Will receive Floseal as treatment for posterior epistaxis.
Other Name: non applicable
Floseal, a hemostatic agent, is an effective treatment for anterior epistaxis as well as numerous other acute bleeding conditions throughout the body. The investigators hypothesize that Floseal is an effective treatment for posterior epistaxis. If so, then this will also lead to significant cost savings in comparison to any other method of treatment of posterior epistaxis. The investigators have planned a prospective, nonblinded, nonrandomised study with a total of 40 subjects with posterior epistaxis to be included in this study.